Xiaodong Li

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2008 · 932 citations · Full text

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Xiaodong Li, Michael S. Ominsky, Kelly Warmington et al. · Journal of Bone and Mineral Research · 2008 · 773 citations

Sclerostin, Immunology, Orthopaedic Surgery +17

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Ji Li, Ildiko Sarosi, Russell C. Cattley et al. · Bone · 2006 · 429 citations

Mechanobiology, Sclerostin, Dkk1-mediated Inhibition +8

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL

Paul J. Kostenuik, Hung Q. Nguyen, James McCabe et al. · Journal of Bone and Mineral Research · 2008 · 428 citations

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

Victoria Shalhoub, Edward Shatzen, Sabrina C. Ward et al. · Journal of Clinical Investigation · 2012 · 401 citations · Full text

Chronic Fgf23 Neutralization, Renal Pathology, Renal Inflammation +21